Population pharmacokinetic analysis of thrombomodulin alfa to support dosing rationale in patients with renal impairment

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|4|3|210-217

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.4, Iss.3, 2015-03, pp. : 210-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The dosing of anidulafungin does not require adjustment in patients with hepatic or renal impairment

By  

Inpharma, Vol. 1, Iss. 1585, 2007-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Retrospective Population Pharmacokinetic Analysis of Levetiracetam in Children and Adolescents with Epilepsy: Dosing Recommendations

By Toublanc Nathalie  

Clinical Pharmacokinetics, Vol. 47, Iss. 5, 2008-01 ,pp. : 333-341

Adis International

Access to resources Recommend Favorite

Antiretroviral Therapy: Pharmacokinetic Considerations in Patients with Renal or Hepatic Impairment

By McCabe Sarah M.   Qing   Slish Judianne C.   Catanzaro Linda M.   Sheth Neha   DiCenzo Robert   Morse Gene D.  

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 153-172

Adis International

Access to resources Recommend Favorite

Population pharmacokinetic analysis of fexofenadine in Japanese pediatric patients

By Martinez Jean-Marie   Khier Sonia   Morita Shigemichi   Rauch Clémence   Fabre David  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 41, Iss. 2, 2014-04 ,pp. : 187-195

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic modeling of tranexamic acid for patients undergoing cardiac surgery with normal renal function and model simulations for patients with renal impairment

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 5, 2015-07 ,pp. : 294-307

John Wiley & Sons Inc

Access to resources Recommend Favorite